(Please also see Limited Submission Funding Opportunities Above and COS Pivot for Customized Searches)
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The initial award will be for two years, $150,000 per year ($300,000 total) with the opportunity for up to two additional years of funding (up to four years total for $600,000).
Key Application Dates
> July 1, 2016 Application Deadline
> October 2016 Notification of Finalists
> November 18, 2016 Finalist Interviews
> December 2016 Notification of Awardees
> January 1, 2017 Funding Begins
Supports, in the early stages of their careers, young investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. The Klingenstein Fund and the Simons Foundation recognize that to accomplish this goal it is necessary to encourage a variety of new approaches. Several areas within the neurosciences are of particular interest:
Cellular and molecular neuroscience—Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior.
Neural systems—Studies of the integrative function of the nervous system.
Clinical research—Studies designed to improve the prevention, diagnosis, treatment and our understanding of the causes of neurological and psychiatric disorder
APPLICATIONS DUE MARCH 1, 2016
Last Updated: 2/12/16